Tirzepatide (Mounjaro, Zepbound) 50 mg

ZPHC logo

Tirzepatide 50 mg injectable lyophilized powder by ZPHC. 5 vials (10 mg each). Dual GLP-1/GIP agonist for weight loss. Fastest U.S. delivery: 2 business days tracking.

151.4$

Out of stock

ZPHC Tirzepatide (Mounjaro) 50 mg: Weight loss and metabolic health

ZPHC Tirzepatide (Mounjaro) 50 mg is designed to aid weight management and improve glycemic control, gaining recognition among those seeking effective solutions for obesity and metabolic health. This innovative medication combines multiple mechanisms to facilitate weight loss and enhance overall metabolic function. You can purchase ZPHC Tirzepatide (Mounjaro) 50 mg from AASDEPOT, a trusted provider known for delivering high-quality products at competitive prices.

Pharmacological classification

GLP-1 receptor agonist: Tirzepatide is a novel dual agonist targeting both GLP-1 and GIP receptors, making it effective for improving glycemic control and promoting weight loss.

Mechanism of action

Weight loss and glycemic control

Tirzepatide works by enhancing insulin secretion in response to meals while suppressing glucagon release. This leads to reduced appetite and increased satiety, promoting significant weight loss and better management of blood sugar levels.

Therapeutic benefits

Weight management

ZPHC Tirzepatide (Mounjaro) 50 mg is ideal for individuals looking to achieve sustainable weight loss. Users often report reduced cravings and improved motivation for maintaining a healthy lifestyle.

Improved metabolic health

In addition to aiding weight loss, Tirzepatide can enhance metabolic markers, including blood glucose levels and lipid profiles, contributing to overall health benefits.

Recommended dosage

Typical dose: 2.5–15 mg once weekly by subcutaneous injection for 12–24 weeks. Individual titration may be required. It is essential to tailor the dosage to individual needs and follow healthcare-provider recommendations. Consulting a healthcare professional is advised before starting any new medication.

Common side effects

While generally well‑tolerated, users may experience mild side effects such as nausea, diarrhea, or abdominal discomfort.💡 Discover ZPHC Tirzepatide (Mounjaro) 50 mg for effective weight loss management. This medication represents the future of sustainable weight control and is designed to target body fat while preserving lean muscle mass. With its unique mechanism of action, it helps regulate appetite and improves glucose control, potentially defending against diabetes and reducing the risk of obesity‑related conditions. Experience a transformative approach to your health journey!📝 Discover our comparison of Semaglutide, Tirzepatide, and Retatrutide.

You may also like…

U.S. WAREHOUSE #4
OUT OF STOCK
ZPHC Retatrutide 40 mg

Retatrutide 40 mg

202.6$
U.S. WAREHOUSE #4
Spectrum Pharma IGF-1 LR3 1.4mg Pen

IGF-1 LR3 1.4 mg pen

157.1$
U.S. WAREHOUSE #4
OUT OF STOCK
ZPHC Retatrutide pen 30 mg

Retatrutide AQ pen – 30 mg

207.2$
U.S. WAREHOUSE #4
OUT OF STOCK
ZPHC Ultra Rehab 50mg Kit detailZPHC Ultra Rehab 50mg Kit

Ultra rehab mix (BPC-157 + TB-500)

155.9$

SUBSCRIBE NOW!